Christopher Robinson/LinkedIn
May 20, 2026, 07:27
Christopher Robinson: SNRI vs SSRI and the Risk of Hypertensive Disorders of Pregnancy
Christopher Robinson, Associate Professor Maternal Fetal Medicine at University of South Carolina, shared a post on LinkedIn:
“AJOG Presents: Serotonin-norepinephrine reuptake inhibitors vs selective serotonin reuptake inhibitors and the risk of hypertensive disorders of pregnancy.”
Title: Serotonin-norepinephrine reuptake inhibitors vs selective serotonin reuptake inhibitors and the risk of hypertensive disorders of pregnancy
Authors: Anick Bérard, Yves Mufike Lumu, Odile Sheehy, Gabra Nohmie, Narimene Ait Belkacem
Proceed to the video attached to the post.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
May 20, 2026, 10:04ACOG’s Rate Navigator Report is Officially Live – ACOG
-
May 20, 2026, 10:01Efficacy and Safety of a One-Step Warming Protocol of Vitrified Blastocysts – Fertility and Sterility
-
May 20, 2026, 09:36Pelvic Pain and Endometriosis Featured in ISUOG World Congress 2026 Programme – ISUOG
-
May 20, 2026, 07:59Yogita Date: Connecting with Brilliant Minds at Elevate 2026
-
May 20, 2026, 07:45George Lainas: Embryo or Endometrium? IVF Experts to Discuss Key Drivers of Implantation
-
May 20, 2026, 07:38Sharon Davidesko Highlights the Need to Normalize Vulval Anatomy Education
-
May 20, 2026, 04:59Chiara Innocenzi: Grateful to IJGC for Welcoming Me to Collaborate on This Forward-Thinking Educational Project
-
May 20, 2026, 04:29Evidence-Based Prepregnancy Care for Maternal and Neonatal Health – JAMA
-
May 19, 2026, 17:47Fertility 2027 Opens Abstract Submissions for Researchers and Experts – Fertility Conferences